PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Psychiatry

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1176/APPI.AJP.163.3.387PMID 16513858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rate of increase of plasma drug level influences subjective response in humans

  2005cited by this paper
• Subjective and behavioral effects of diazepam depend on its rate of onset

  2005cited by this paper
• A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.

  2004cited by this paper
• Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications

  2002cited by this paper
• Pharmacokinetic Imaging

  2002cited by this paper
• Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.

  2001cited by this paper
• [11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

  2001cited by this paper
• Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.

  2001influential reference
• Single‐ and Multiple‐Dose Pharmacokinetics of an Oral Once‐a‐Day Osmotic Controlled‐Release OROS® (methylphenidate HC1) Formulation

  2000cited by this paper
• Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT.

  2000cited by this paper
• An evaluation of the abuse potential of modafinil using methylphenidate as a reference

  2000cited by this paper
• Stimulant medications : Current knowledge and unmet needs in pediatrics psychopharmacology

  1999cited by this paper
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

  1999cited by this paper
• Stimulant medications.

  1999cited by this paper
• Regulation of striatal dopamine receptors by estrogen

  1999cited by this paper
• Central Nervous System Pharmacokinetics of Psychiatric Drugs

  1999cited by this paper
• Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.

  1998influential reference
• Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.

  1998influential reference
• Relationship between subjective effects of cocaine and dopamine transporter occupancy

  1997cited by this paper
• Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain

  1997cited by this paper
• The role of positron emission tomography in pharmacokinetic analysis.

  1997cited by this paper
• Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone.

  1996cited by this paper
• Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography.

  1996cited by this paper
• Pharmacokinetics and pharmacodynamics of cocaine.

  1995cited by this paper
• Alprazolam absorption kinetics affects abuse liability *

  1995cited by this paper
• Human abuse liability assessment by measurement of subjective and physiological effects.

  1989cited by this paper
• Psychopharmacology: The third generation of progress

  1988cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper
• Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.

  1977cited by this paper

• Methylphenidate Promotes a Frontoparietal-Dominant Brain State Improving Cognitive Performance: A Randomized Trial

  2025cites this paper
• Imaging Procedure and Clinical Studies of [18F]FP-CIT PET

  2024cites this paper
• Examining the Myth of Prescribed Stimulant Misuse among Individuals with Attention-Deficit/Hyperactivity Disorder: A Systematic Review

  2024cites this paper
• Are all ADHD medications created equal? Exploring the differences that enable evening dosing

  2024cites this paper
• An exploratory analysis of the performance of methylphenidate regimens based on a PKPD model of dopamine and norepinephrine transporter occupancy

  2023cites this paper
• Preclinical Models of Attention Deficit Hyperactivity Disorder: Neurobiology, Drug Discovery, and Beyond

  2023cites this paper
• A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice

  2023influential citation
• Nicotine and the developing brain: Insights from preclinical models.

  2022cites this paper
• Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate

  2022cites this paper
• Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models

  2022cites this paper
• The effects of first-dose methylphenidate on the neural signatures of visual selective attention in children with attention-deficit/hyperactivity disorder.

  2022cites this paper
• Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles.

  2022cites this paper
• ADHD stimulant medication misuse and considerations for current prescribing practice: a literature review

  2021cites this paper
• The Brain Reward System

  2021cites this paper
• Positron Emission Tomography of the

  2020cites this paper
• An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations

  2020cites this paper
• Investigation of Efficacy of Short-Acting Methylphenidate (Ritalin) and Long-Acting (Matoride) on Symptoms of Attention Deficit Hyperactivity Disorder in Children Aged 6–18 Years: A Single-Blind, Randomized Clinical Trial

  2020cites this paper
• Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France

  2020cites this paper
• Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change

  2020cites this paper
• Prescription Stimulants

  2020cites this paper
• Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model

  2020cites this paper
• Attention Deficit Hyperactivity Disorder

  2020cites this paper
• The rate of dasotraline brain entry is slow following intravenous administration

  2020cites this paper
• Methylphenidate boosts choices of mental labor over leisure depending on striatal dopamine synthesis capacity

  2020cites this paper
• Inducing a Functional-Pharmacological Coupling in the Human Brain to Achieve Improved Drug Effect

  2020cites this paper
• The effect of Methylphenidate on Energy Expenditure in Individuals with Obesity: A Randomized, Double-Blind, Placebo Controlled Pilot Trial

  2019cites this paper
• Reduced Uptake on Dopamine Transporter Imaging by Methylphenidate

  2019cites this paper
• Considering noradrenergically mediated facilitation of sensory signal processing as a component of psychostimulant-induced performance enhancement.

  2019cites this paper
• Baicalin regulates the dopamine system to control the core symptoms of ADHD

  2019cites this paper
• Prescription Stimulants: From Cognitive Enhancement to Misuse.

  2019cites this paper
• Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover Study

  2019cites this paper
• Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial

  2018cites this paper
• The Co-Occurrence of ADHD and Substance Use Disorders

  2018cites this paper
• Tout ce que vous devez connaître sur le méthylphénidate (sans oser le demander

  2018cites this paper
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

  2018cites this paper
• Attention-Deficit/Hyperactivity Disorder and Substance Abuse

  2018cites this paper
• [All you need to know about methylphenidate (and dared not ask)].

  2018cites this paper
• The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone.

  2018cites this paper
• The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention‐deficit/hyperactivity disorder and other psychiatric comorbidities

  2018cites this paper
• The role of impulsivity in psychostimulant‐ and stress‐induced dopamine release: Review of human imaging studies

  2017cites this paper
• An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder Treatment

  2017cites this paper
• Tyrosinase-Based Biosensors for Selective Dopamine Detection

  2017cites this paper
• Disrupted Glutamatergic Transmission in Prefrontal Cortex Contributes to Behavioral Abnormality in an Animal Model of ADHD

  2017cites this paper
• ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

  2017cites this paper
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

  2017cites this paper
• Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers

  2017cites this paper
• Contribution of Clinical Neuroimaging to the Understanding of the Pharmacology of Methylphenidate.

  2017cites this paper
• Non-medical and illicit use of psychoactive drugs

  2017cites this paper
• Methylphenidate Causes Behavioral Impairments and Neuron and Astrocyte Loss in the Hippocampus of Juvenile Rats

  2016cites this paper
• Methylphenidate does not enhance visual working memory but benefits motivation in macaque monkeys.

  2016cites this paper
• Absorption Differences between Immediate-Release Dexmethylphenidate and dl-Methylphenidate

  2016cites this paper
• Intravenous Use of Prescription Psychostimulants; A Comparison of the Pattern and Subjective Experience between Different Methylphenidate Preparations, Amphetamine and Cocaine

  2016cites this paper
• Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology

  2016cites this paper
• Detecting dopamine dysfunction with pharmacological MRI

  2016cites this paper
• The effects of Psychotropic drugs On the Developing brain (ePOD) study: methods and design

  2016cites this paper
• Cognition and comorbidity in ADHD: The role of methylphenidate and development

  2016cites this paper
• Detecting dopamine dysfunction with pharmacological MRI

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) Cognition and comorbidity in ADHD : The role of methylphenidate and development

  2016cites this paper
• Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders.

  2016cites this paper
• Treatment of Comorbid Substance Use Disorders and ADHD in Youth

  2016cites this paper
• Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage

  2016cites this paper
• How fast and how often: The pharmacokinetics of drug use are decisive in addiction.

  2015cites this paper
• Effect modification by age of methylphenidate on the development of the dopaminergic system in the brain “ePOD-MPH”

  2015cites this paper
• Antidepressant drug development: Focus on triple monoamine reuptake inhibition

  2015cites this paper
• Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate

  2015cites this paper
• Prenatal Exposure to Methylphenidate Affects the Dopamine System and the Reactivity to Natural Reward in Adulthood in Rats

  2015cites this paper
• Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.

  2015cites this paper
• Misuse of Methylphenidate.

  2015cites this paper
• Development of a Physiologically Based Model to Describe the Pharmacokinetics of Methylphenidate in Juvenile and Adult Humans and Nonhuman Primates

  2014cites this paper
• Drug Use and Its Consequences

  2014cites this paper
• Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

  2014cites this paper
• AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

  2014cites this paper
• Avaliação neuropsicológica das funções executivas e da atenção antes e depois do uso do metilfenidato em crianças com transtorno de déficit de atenção/hiperatividade

  2014cites this paper
• The Potential for Misuse and Abuse of Medications in ADHD: A Review

  2014cites this paper
• Ghost pill: knowledge and awareness of this phenomenon among health care professionals

  2014cites this paper
• Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis

  2014cites this paper
• In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [¹⁸F]FE-PE2I.

  2014cites this paper
• Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature.

  2014cites this paper
• The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.

  2014cites this paper
• The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design

  2014cites this paper
• Human abuse liability evaluation of CNS stimulant drugs.

  2014cites this paper
• Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.

  2014cites this paper
• An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder

  2014cites this paper
• Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder☆

  2013cites this paper
• Differential Influences of Ethanol on Early Exposure to Racemic Methylphenidate Compared with Dexmethylphenidate in Humans

  2013influential citation
• A Young Man with History of ADHD and Methamphetamine Use

  2013cites this paper
• Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

  2013cites this paper
• Cognitive and electrophysiological responses to dopaminergic manipulations

  2013cites this paper
• The dopamine hypothesis of ADHD and brain response to stimulant medication.

  2013cites this paper
• ADHD and criminality: could treatment benefit prisoners with ADHD who are at higher risk of reoffending?

  2013cites this paper
• A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to D-amfetamine, methylphenidate and modafinil.

  2013cites this paper
• Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

  2013cites this paper
• Methylphenidate reduces functional connectivity of nucleus accumbens in brain reward circuit

  2013cites this paper
• Intravenous abuse of methylphenidate.

  2013cites this paper
• The Role of Positron Emission Imaging (PET) in Understanding Addiction

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) Antidepressants and the adolescent brain : Changing the course of neurodevelopment ?

  2013cites this paper
• Modeling cognitive dysfunction in neurofibromatosis-1.

  2013cites this paper
• The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats.

  2013cites this paper
• Attention deficit hyperactivity disorder in prison inmates

  2012cites this paper
• Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder

  2012cites this paper